Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD -Q1 group results

Aug 1 (Reuters)-  
             Taisho Pharmaceutical Holdings Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   3 months ended      3 months ended       Year to  
                  Jun 30, 2016        Jun 30, 2015     Mar 31, 2017  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales               69.43               69.21           285.00     
                   (+0.3 pct)          (+1.2 pct)       (-1.8 pct)   
  Operating            9.11                5.23            29.50     
                   (+74.0 pct)         (-39.2 pct)      (+2.2 pct)   
  Recurring           10.42                7.49            36.50     
                   (+39.1 pct)         (-30.4 pct)      (-0.7 pct)   
  Net                  6.95                4.69            24.00     
                   (+48.2 pct)         (-29.6 pct)      (+6.8 pct)   
  EPS               86.92 yen           57.81 yen       300.37 yen   
  EPS Diluted       86.86 yen           57.78 yen                    
  Ann Div                              100.00 yen       110.00 yen   
  -Q2 div                               50.00 yen        50.00 yen   
  -Q4 div                               50.00 yen        60.00 yen   
   
  NOTE - Taisho Pharmaceutical Holdings Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Taisho Pharmaceutical Holdings Co

See all news